Outline

Volume: 01, Issue: 02, Page: 01-03

Unveiling the intriguing role of nuclear microRNA-34a: A journey from discovery to functional exploration

Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, Dhaka, Bangladesh

*Corresponding author:

Email address: kkdutta@bsmrstu.edu.bd (Khokon Kumar Dutta)

doi: https://doi.org/10.69517/jber.2024.01.02.0001

Share:

Received:
27 July 2024

Revised:
16 August 2024

Accepted:
25 August 2024

Published:
03 September 2024

Highlights

  • Traces the journey of microRNA-34a (miR-34a) from its discovery to its novel functional roles within the nucleus.
  • Discusses the pioneering research by Dutta et al. (2007) that established miR-34a’s context-specific influence on cell proliferation. In 2007, Dutta et al for the first time discovered the presence of mature microRNA-34a inside the cell nucleus.
  • Highlights the findings by Ohno et al. (2022) revealing miR-34a’s involvement in the release of paused RNA Polymerase II via the DDX21-CDK9 complex.
  • Emphasizes the need for further investigation into the molecular mechanisms governing miR-34a’s nuclear functions and its potential as a therapeutic target.

Abstract

MicroRNAs (miRNAs) are endogenous ~22 nt RNAs. miRNAs are traditionally considered primarily cytoplasmic molecules that regulate gene expression posttranscriptionally by targeting mRNAs for degradation or translational repression. In the canonical pathway of biogenesis, pri-miRNAs are transcribed from DNA sequences inside the cell nucleus. Pri-miRNAs are then processed by Drosha into pre-miRNAs and exported to the cytoplasm via the exportin 5 (XPO5)/RanGTP complex. Pre-miRNAs are then processed into mature miRNA duplexes by the RNase III endonuclease Dicer. In the intricate world of molecular biology, the discovery of mature microRNA-34a (miR-34a) inside the nucleus of atypical rat kidney epithelial cells (karyomegalic cells) has ignited scientific curiosity, revealing its multifaceted roles in cellular processes. This perspective embarks on a journey, beginning with the groundbreaking work and culminating in the recent breakthrough, shedding light on the association of miR-34a with cell proliferation and its exploration within the nuclear landscape. Other examples of mature miRNAs that have been reported to be present inside the nucleus include miR-21, miR-122, miR-223, and miR-29b.

Keywords

Cell nucleus, MicroRNA, Nuclear miR-34a, RNA activation, Karyomegalic cells

MicroRNAs (miRNAs) are endogenous ~22 nt RNAs. miRNAs are traditionally considered primarily cytoplasmic molecules that regulate gene expression posttranscriptionally by targeting mRNAs for degradation or translational repression (Bartel, 2004 popup link icon). In the canonical pathway of biogenesis, pri-miRNAs are transcribed from DNA sequences inside the cell nucleus. Pri-miRNAs are then processed by Drosha into pre-miRNAs and exported to the cytoplasm via the exportin 5 (XPO5)/RanGTP complex. Pre-miRNAs are then processed into mature miRNA duplexes by the RNase III endonuclease Dicer (O’Brien et al., 2018 popup link icon). In the intricate world of molecular biology, the discovery of mature microRNA-34a (miR-34a) inside the nucleus of atypical rat kidney epithelial cells (karyomegalic cells) has ignited scientific curiosity, revealing its multifaceted roles in cellular processes. This perspective embarks on a journey, beginning with the groundbreaking work of Dutta et al. (2007 popup link icon), and culminating in the recent breakthrough by Ohno et al. (2022 popup link icon), shedding light on the association of miR-34a with cell proliferation and its exploration within the nuclear landscape. Other examples of mature miRNAs that have been reported to be present inside the nucleus include miR-21, miR-122, miR-223, and miR-29b (Billi et al., 2024 popup link icon).
Dutta et al. (2007 popup link icon) laid the foundation for our understanding of miR-34a by revealing its nuanced relationship with cell proliferation. Their pioneering research illuminated how dysregulation of miR-34a profoundly influences cell proliferation, prompting extensive investigations into its regulatory mechanisms and downstream effects.
Through meticulous in situ hybridization experiments, they revealed a striking pattern: while mature miR-34a exhibited robust expression in approximately 50% of human cancers, its presence was nearly negligible in many others. This finding underscores the context-specific nature of the impact of miR-34a, suggesting a sophisticated view of its functional role. The work of Dutta et al. (2007 popup link icon) not only expanded our comprehension of miR-34a but also set the stage for subsequent breakthroughs in the field.
Dutta et al. (2007 popup link icon) revealed the unexpected presence of mature miR-34a within the nucleus of rat kidney cells (karyomegalic cells) during their in situ microRNA detection experiment with rat kidney cells. Subsequently, Ohno et al. (2022 popup link icon) elucidated the involvement of nuclear miR-34a in facilitating the release of paused RNA polymerase II (Pol II) through the DDX21-CDK9 complex. These findings expand our understanding of miR-34a beyond its established role in the cytoplasm, revealing a novel layer of regulatory control within the nucleus. The identification of nuclear miR-34a has challenged the conventional notion that microRNAs predominantly function in the cytoplasm, opening avenues for further exploration.
The journey from Dutta et al. (2007 popup link icon) seminal observations of mature miR-34a in the nucleus to Ohno et al. (2022 popup link icon)'s recent insights underscores the dynamic nature of miR-34a. The nuclear localization of miR-34a prompts intriguing questions about its specific targets and the regulatory networks it modulates within the nucleus. Recent studies suggest that nuclear miR-34a may regulate genes involved in crucial cellular processes, including DNA repair, cell cycle progression, and apoptosis. Its interaction with the DDX21-CDK9 complex may play a role in modulating the transcriptional landscape by facilitating the release of paused RNA Pol II. This was the first experimental demonstration that miR-34a functions in RNA activation (RNAa).
RNAa is a process in which small RNAs such as miRNAs upregulate gene expression rather than suppress it. This newfound dimension adds complexity to the functional implications of miR-34a, urging researchers to decipher the intricacies of its nuclear activities. Furthermore, the presence of miR-34a in the cytoplasmic, mitochondrial (Giuliani et al., 2018 popup link icon), and nuclear compartments suggests a sophisticated regulatory mechanism. Understanding the interplay among these locales and deciphering the signals governing the subcellular localization of miR-34a will offer valuable insights into its overall function.
A few noteworthy examples can be highlighted here. Numerous studies have demonstrated that nuclear miRNAs play crucial roles in regulating disorders associated with glycolipid metabolism. Specifically, miR-552-3p exacerbates hepatic glycolipid metabolic disorders by modulating the transcriptional activities of LXRα and FXR within the nucleus. This evidence supports the potential of miR-552-3p as a promising therapeutic target for combating metabolic diseases (Fan et al., 2021 popup link icon).
Hypoxia is a critical pathological condition associated with various diseases, such as myocardial infarction and cerebral ischemia, where it disrupts tissue function and triggers a rapid, intricate response at the molecular and cellular levels. miR-210-3p, a well-known hypoxamiR, is notably upregulated in the nuclear compartment following hypoxic stimulation. These findings reveal an additional layer of molecular complexity in the physiological response to ischemic tissue (Turunen et al., 2019 popup link icon).
Nuclear miRNAs have emerged as critical transcriptional regulators that influence a wide spectrum of cancer hallmarks, including proliferation, invasion, metastasis, migration, apoptosis, and angiogenesis. By targeting promoters or enhancers, these miRNAs can modulate gene expression and thereby drive tumorigenesis and progression. For example, miRNA-10a suppresses breast cancer development through its interaction with the homeobox D4 promoter, interfering with promoter-associated transcripts (Tan et al., 2009 popup link icon). Moreover, miR-339 inhibits breast cancer cell proliferation by upregulating the expression of the tumor suppressor G protein-coupled estrogen receptor 1 via enhancer switching, suggesting its potential as a therapeutic target, especially for triple-negative breast cancer (Liang et al., 2021 popup link icon). In lung cancer, miR-1236-3p and miR-370-5p collectively curtail cell proliferation, migration, and invasion by targeting the P21 gene promoter and consequently increasing its expression (Li et al., 2017 popup link icon).
As exploration of nuclear miR-34a has progressed, researchers have sought to delve deeper into the molecular mechanisms governing its nuclear functions. Elucidating its specific interactions and downstream effects within the nucleus will not only enrich our understanding of miR-34a but also reveal new therapeutic avenues that target its regulatory pathways. Identifying the direct targets of nuclear miR-34a and investigating the modulated genes and pathways will provide a comprehensive picture of its regulatory impact on cellular processes. Moreover, understanding the factors governing the nuclear and mitochondrial translocation of miR-34a will shed light on the intricate molecular machinery orchestrating its subcellular distribution. The dynamic nature of microRNAs, including miR-34a, presents exciting challenges, inspiring further exploration into their nuclear functions. Deciphering these intricacies will not only deepen our knowledge of gene regulation but also offer novel therapeutic interventions. Targeting nuclear miR-34a could emerge as a strategy for modulating transcriptional processes, presenting potential avenues for precision medicine in various pathological conditions.
The discovery of nuclear miR-34a represents a significant milestone in the evolving narrative of microRNA research. From its initial association with proliferation to its newfound role within the nucleus, miR-34a continues to captivate researchers with its multifaceted functions. This perspective highlights the transformative journey from discovery to functional exploration, emphasizing the need for continued investigation into the complex regulatory landscape of nuclear microRNAs. As we stand on the brink of a new era in microRNA research, the dual nature of miR-34a prompts researchers to unravel the mysteries within the nucleus. The interplay of the cytoplasmic, mitochondrial, and nuclear functions of miR-34a signifies an exciting frontier in molecular biology, which is poised to reshape our understanding of gene regulation and cellular dynamics. The ongoing narrative of miR-34a holds the potential to unlock novel therapeutic strategies and deepen our comprehension of the intricate molecular interactions within the cellular landscape.

Declaration by author

The authors' guidelines were used to generate the manuscript with the assistance of ChatGPT, an artificial intelligence program developed by OpenAI.

Acknowledgements

The author would like to express his sincere gratitude to Professor Shinya Toyokuni, MD, PhD, Kyoto University (present location, Nagoya University), Japan, for supporting, guiding and supervising the first discovery of mature microRNA-34a inside the nucleus of rat kidney cells.

Ethical approval statement

None to declare.

Data availability statement

Not applicable.

Informed consent statement

Not applicable.

Conflict of interest

The author declare no competing interests.

Author contributions

Khokon Kumar Dutta contributed to the design and writing of this editorial.

References

Bartel DP, 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116: 281-297. https://doi.org/10.1016/s0092-8674(04)00045-5

Billi M, De Marinis E, Gentile M, Nervi C and Grignani F, 2024. Nuclear miRNAs: Gene Regulation Activities. International Journal of Molecular Sciences, 25(11): 6066. https://doi.org/10.3390/ijms25116066

Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, Hu Q, Yoshihara M, Ohara H, Takehashi M, Shinohara T, Masutani H, Onuki J and Toyokuni S, 2007.  Association of microRNA-34a overexpression with proliferation is cell type dependent. Cancer Science, 98: 1845–1852. https://doi.org/10.1111/j.1349-7006.2007.00619.x

Fan L, Lai R, Ma N, Dong Y, Li Y, Wu Q, Qiao J, Lu H, Gong L, Tao Z, Chen J, Xie Q and Ren J, 2021. miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder. Journal of Hepatology, 74: 8–19. https://doi.org/10.1016/j.jhep.2020.07.048

Giuliani A, Cirilli I, Prattichizzo F, Mensà E, Fulgenzi G, Sabbatinelli J, Graciotti L, Olivieri F, Procopio AD, Tiano L and Rippo MR, 2018. The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells. Aging (Albany NY), 10(10): 2855-2873. https://doi.org/10.18632/aging.101591

Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K and Chen Z, 2017. Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells. Tumor Biology, 39: 1010428317710824. https://doi.org/10.1177/1010428317710824

Liang Y, Lu Q, Li W, Zhang D, Zhang F, Zou Q, Chen L, Tong Y, Liu M, Wang S, Li W, Ren X, Xu P, Yang Z, Dong S, Zhang B, Huang Y, Li D, Wang H and Yu W, 2021. Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network. Nucleic Acids Research, 49: 8556–8572.  https://doi.org/10.1093/nar/gkab626

O’Brien J, Hayder H, Zayed Y and Peng C, 2018. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Frontiers in Endocrinology, 3 (9): 402. https://doi.org/10.3389/fendo.2018.00402

Ohno SI, Oikawa K, Tsurui T, Harada Y, Ono K, Tateishi M, Mirza A, Takanashi M, Kanekura K, Nagase K, Shimada Y, Kudo Y, Ikeda N, Ochiya T, Wang X and Kuroda M, 2022. Nuclear microRNAs release paused Pol II via the DDX21-CDK9 complex. Cell Reports, 39(2): 110673. https://doi.org/10.1016/j.celrep.2022.110673

Tan Y, Zhang B, Wu T, Skogerbø G, Zhu X, Guo X, He S and Chen R, 2009. Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Molecular Biology, 10: 12. https://doi.org/10.1186/1471-2199-10-12

Turunen TA, Roberts TC, Laitinen P, Väänänen MA, Korhonen P, Malm T, Herttuala SY and Turunen MP, 2019.  Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress. Scientific Reports, 9: 10332. https://doi.org/10.1038/s41598-019-46841-1

 

How to cite

Dutta KK 2024. Unveiling the intriguing role of nuclear microRNA-34a: A journey from discovery to functional exploration. Journal of Bioscience and Environment Research, 1(2): 1-3. https://doi.org/10.69517/jber.2024.01.02.0001

CrossMark Update
CROSSMARK Color horizontal
Article Metrics
[stm-calc id="1576"]